Apellis Pharmaceuticals, Inc. - Penyata Pendapatan (TTM)

Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060

Penyata Pendapatan (TTM)

Apellis Pharmaceuticals, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 1 251 251 251 256 67 81 97 113 75 106 185 273 397 524 629 715 781 776 755
Perubahan (%) 38,699.69 0.00 0.25 1.99 -74.03 21.61 19.39 16.98 -33.28 40.39 74.27 47.87 45.34 32.14 19.98 13.75 9.25 -0.71 -2.73
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 471 304 318 399 372 426 404 359 368 393 419 421 426 413 400 397 417 445 461 441
Perubahan (%) -35.48 4.85 25.20 -6.70 14.58 -5.26 -10.95 2.42 6.71 6.53 0.55 1.25 -3.09 -3.13 -0.75 5.11 6.71 3.56 -4.42
% daripada Hasil 72,841.02 121.12 127.00 158.61 145.10 640.10 498.69 371.95 325.67 520.90 395.25 228.04 156.13 104.11 76.32 63.13 58.34 56.99 59.44 58.41
Keuntungan Operasi Kasar -470 -53 -68 -147 -116 -360 -323 -263 -255 -317 -313 -236 -153 -16 124 232 298 336 315 314
Perubahan (%) -88.73 27.82 117.63 -21.53 211.07 -10.23 -18.56 -2.93 24.43 -1.52 -24.42 -35.17 -89.35 -861.06 86.79 28.53 12.80 -6.37 -0.25
% daripada Hasil -72,741.02 -21.12 -27.00 -58.61 -45.10 -540.10 -398.69 -271.95 -225.67 -420.90 -295.25 -128.04 -56.13 -4.11 23.68 36.87 41.66 43.01 40.56 41.59
SG&A 122 139 150 171 180 177 187 202 234 277 328 376 443 501 528 545 521 501 501 504
Perubahan (%) 13.91 7.94 13.66 5.13 -1.69 6.00 7.60 16.19 18.32 18.37 14.68 17.87 12.93 5.47 3.16 -4.34 -3.88 -0.03 0.61
% daripada Hasil 18,943.81 55.62 60.04 68.07 70.16 265.57 231.49 208.62 207.22 367.48 309.83 203.89 162.52 126.28 100.79 86.66 72.88 64.13 64.56 66.78
R&D -142 21 21 21 31 31 31
Perubahan (%) -115.00 0.00 0.00 0.00
% daripada Hasil -22,058.36 8.53 8.53 8.34 37.79 31.65 27.06
OpEx 450 464 490 570 573 603 622 592 633 670 747 797 870 914 928 942 939 946 962 945
Perubahan (%) 3.09 5.56 16.20 0.61 5.20 3.12 -4.82 6.99 5.85 11.42 6.76 9.09 5.08 1.59 1.48 -0.36 0.83 1.66 -1.80
% daripada Hasil 69,726.47 185.27 195.57 226.68 223.60 905.67 767.97 612.22 559.95 888.38 705.08 431.93 318.65 230.39 177.11 149.80 131.23 121.11 124.00 125.19
Pendapatan operasi -450 -214 -240 -318 -317 -536 -541 -495 -520 -595 -641 -613 -597 -517 -404 -313 -223 -165 -186 -190
Perubahan (%) -52.48 12.07 32.89 -0.49 69.31 0.82 -8.45 5.04 14.36 7.75 -4.40 -2.59 -13.33 -21.85 -22.52 -28.68 -26.13 12.87 2.06
% daripada Hasil -69,626.47 -85.27 -95.57 -126.68 -123.60 -805.67 -667.97 -512.22 -459.95 -788.38 -605.08 -331.93 -218.65 -130.39 -77.11 -49.80 -31.23 -21.11 -24.00 -25.19
Perbelanjaan Faedah -24 -30 -30 -27 -20 -13 -18 -22 -28 -33 -32 -31 -30 -30 -29 -31 -36 -40 -44 -46
Perubahan (%) 23.41 0.86 -10.41 -26.68 -33.24 32.95 26.60 25.22 16.91 -3.09 -3.50 -1.94 -1.12 -1.90 6.96 16.82 11.40 10.11 4.03
% daripada Hasil -3,755.11 -11.94 -12.05 -10.77 -7.74 -19.89 -21.75 -23.06 -24.68 -43.26 -29.86 -16.53 -10.96 -7.46 -5.54 -4.94 -5.07 -5.17 -5.73 -6.13
Pendapatan bersih -536 -345 -360 -460 -520 -746 -702 -638 -634 -652 -691 -657 -606 -529 -417 -333 -250 -198 -224 -228
Perubahan (%) -35.70 4.30 27.96 13.01 43.49 -5.99 -9.01 -0.67 2.85 5.96 -4.91 -7.77 -12.77 -21.06 -20.22 -24.87 -20.88 13.04 2.01
% daripada Hasil -83,027.40 -137.59 -143.51 -183.18 -202.97 -1,121.27 -866.81 -660.59 -560.92 -864.70 -652.60 -356.07 -222.09 -133.29 -79.62 -52.94 -34.97 -25.32 -28.83 -30.24

Source: Capital IQ

Other Listings
IT:1APLS €24.26
DE:1JK €23.90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista